These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 25424887)

  • 21. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radionuclide Imaging in Congestive Heart Failure: Assessment of Viability, Sarcoidosis, and Amyloidosis.
    Bois JP; Chareonthaitawee P
    Cardiol Clin; 2016 Feb; 34(1):119-32. PubMed ID: 26590784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement.
    Pellikka PA; Holmes DR; Edwards WD; Nishimura RA; Tajik AJ; Kyle RA
    Arch Intern Med; 1988 Mar; 148(3):662-6. PubMed ID: 3341867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.
    Gertz MA; Brown ML; Hauser MF; Kyle RA
    Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.
    Vogelsberg H; Mahrholdt H; Deluigi CC; Yilmaz A; Kispert EM; Greulich S; Klingel K; Kandolf R; Sechtem U
    J Am Coll Cardiol; 2008 Mar; 51(10):1022-30. PubMed ID: 18325442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodality imaging for the diagnosis of infiltrative cardiomyopathies.
    Vidula MK; Bravo PE
    Heart; 2022 Jan; 108(2):98-104. PubMed ID: 34039679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial technetium-99m-pyrophosphate scintigraphy and echocardiography in the diagnosis of cardiac amyloidosis.
    Planinc D; Franceschi D; Zigman M; Jerić M; Pagon LJ; Mihatov S; Rudar M
    Acta Cardiol; 1992; 47(4):391-401. PubMed ID: 1387996
    [No Abstract]   [Full Text] [Related]  

  • 28. Value of classical criteria for diagnosis of cardiac amyloidosis re-evaluated with magnetic resonance.
    Pozo E; Sanz J
    Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1133-6. PubMed ID: 25205232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis.
    Cacciapuoti F
    J Echocardiogr; 2015 Sep; 13(3):84-9. PubMed ID: 26184746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A special case of hypertrophic cardiomyopathy with a differential diagnosis of isolated cardiac amyloidosis or junctophilin type 2 associated cardiomyopathy.
    De Bruijn S; Galloo X; De Keulenaer G; Prihadi EA; Brands C; Helbert M
    Acta Clin Belg; 2021 Apr; 76(2):136-143. PubMed ID: 31478477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive risk stratification of patients with transthyretin amyloidosis.
    Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
    JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease.
    Di Bella G; Pizzino F; Minutoli F; Zito C; Donato R; Dattilo G; Oreto G; Baldari S; Vita G; Khandheria BK; Carerj S
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1307-15. PubMed ID: 25190073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021.
    Li W; Uppal D; Wang YC; Xu X; Kokkinidis DG; Travin MI; Tauras JM
    Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34070853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac amyloidosis: non-invasive diagnosis.
    Hotta VT; Giorgi MCP; Fernandes F; Abduch MCD; Falcão AMGM; Mady C
    Rev Assoc Med Bras (1992); 2020 Mar; 66(3):345-352. PubMed ID: 32520156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges and Strategies in the Diagnosis of Cardiac Amyloidosis.
    Fine NM
    Can J Cardiol; 2020 Mar; 36(3):441-443. PubMed ID: 31964561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary amyloid heart disease presenting as hypertrophic obstructive cardiomyopathy.
    Weston LT; Raybuck BD; Robinowitz M; Brinker JA; Oetgen WJ
    Cathet Cardiovasc Diagn; 1986; 12(3):176-81. PubMed ID: 3015411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake of technetium 99m HDP in cardiac amyloidosis.
    Kulhanek J; Movahed A
    Int J Cardiovasc Imaging; 2003 Jun; 19(3):225-7. PubMed ID: 12834159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear imaging in cardiac amyloidosis.
    Glaudemans AW; Slart RH; Zeebregts CJ; Veltman NC; Tio RA; Hazenberg BP; Dierckx RA
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):702-14. PubMed ID: 19156411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rare presentation of cardiac amyloid deposits isolated to intramural vessels.
    Clemmensen TS; Mølgaard H; Andersen NF; Baerentzen S; Soerensen J; Poulsen SH
    Echocardiography; 2016 Nov; 33(11):1777-1780. PubMed ID: 27600369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.